From Yahoo Finance: 2025-03-29 16:17:00

Jim Cramer discussed 9 stocks recently, including Moderna, Inc. On Wednesday, he analyzed market trends and stock performance. Domestic companies rallied after President Trump announced a 25% tariff on cars made outside the U.S. Cramer predicted disruptions in the market due to new tariffs but highlighted resilient stocks in the S&P leaderboard.

Cramer expressed concerns about the impact of tariffs on the market and highlighted the resilience of certain stocks. A list of 9 stocks discussed by Cramer on Mad Money was compiled, along with hedge fund sentiment data. Following top hedge fund picks has shown to outperform the market significantly since May 2014.

Cramer criticized Moderna, Inc. as a major disappointment of the year. The company, focusing on mRNA-based therapies and vaccines, saw a 7% drop due to negative news. While MRNA ranks 5th on Cramer’s list, he believes AI stocks offer more promise for higher returns. A report on the cheapest AI stock is recommended for investors seeking better opportunities.

Overall, Moderna, Inc. (MRNA) faced criticism from Jim Cramer for its performance this year. The biotech company specializing in mRNA therapies and vaccines experienced a significant drop following negative news reports. While MRNA ranks 5th on Cramer’s list, he believes AI stocks hold greater potential for investors seeking higher returns.

Read more: Jim Cramer Slams Moderna, Inc. (MRNA) as One of the Year’s Biggest Disappointments